TY - JOUR
T1 - Cellular electrophysiological changes in "round heart disease" of turkeys
T2 - A potential basis for dysrhythmias in myopathic ventricles
AU - Einzig, Stanly
AU - Detloff, Barry Lee S.
AU - Borgwardt, Barbara K.
AU - Staley, Nancy A.
AU - Noren, George R.
AU - Benditt, David G.
N1 - Funding Information:
This work was supported in part by grant HL18204 from the National Institutes of Health, the Dwan Family Fund and a grant from the American Heart Association, Minnesota Affiliate.
PY - 1981/11
Y1 - 1981/11
N2 - Summary: Arrhythmias are commonly recorded in "round heart disease", a presumed viral, congestive cardiomyopathy of turkeys. To assess whether cellular electrophysiological changes may be associated with arrhythmia susceptibility, we compared transmembrane action potential characteristics in left and right ventricular endocardial muscle fibres from 19 inbred myopathic turkeys with findings in 13 normal control turkeys (age 1 to 74 days). In left ventricular tissue, as a group, action potential duration at 50% repolarisation (APD50) was reduced in myopathic hearts (201 ± 6(SEM) vs 228 ± 9 ms in controls, P <0.01), while the maximum rate of phase 0 (dV/dtmax) action potential amplitude, diastolic resting membrane potential and action potential duration at 90% repolarisation (APD90) did not differ from control turkeys. By contrast, in myopathic right ventricular tissue, as a group, both APD50 (186 ± 5 vs 206 ± 4 ms in controls) and APD90 (208 ± 4 vs 228 ± 3 ms in controls) were shorter (P <0.01). The plateau potential in both right and left ventricular tissue was significantly higher in inbred turkeys.Since a spectrum of cardiac dilatation and hypertrophy is present in myopathic turkeys, we examined the effect of hypertrophy on action potential characteristics. In "round heart disease" turkeys, left ventricular hypertrophy was characterised by reduced dV/dtmax (98 ± vs 274 ± 26 V s-1, P <0.01) and right ventricular hypertrophy by further shortening of both APD50 (174 ± 7 vs 202 ± 6 ms, P <0.01) and APD90 (193 ± vs 224 ± 5 ms, P <0.01), but no change in dV/dtmax (105 ± 13 vs 120 ± 9 V s-1, P = NS). These results indicate that certain electrophysiological differences (eg reduced action potential duration), may, in part, contribute to dysrhythmia susceptibility in this presumed viral cardiomyopathy model.
AB - Summary: Arrhythmias are commonly recorded in "round heart disease", a presumed viral, congestive cardiomyopathy of turkeys. To assess whether cellular electrophysiological changes may be associated with arrhythmia susceptibility, we compared transmembrane action potential characteristics in left and right ventricular endocardial muscle fibres from 19 inbred myopathic turkeys with findings in 13 normal control turkeys (age 1 to 74 days). In left ventricular tissue, as a group, action potential duration at 50% repolarisation (APD50) was reduced in myopathic hearts (201 ± 6(SEM) vs 228 ± 9 ms in controls, P <0.01), while the maximum rate of phase 0 (dV/dtmax) action potential amplitude, diastolic resting membrane potential and action potential duration at 90% repolarisation (APD90) did not differ from control turkeys. By contrast, in myopathic right ventricular tissue, as a group, both APD50 (186 ± 5 vs 206 ± 4 ms in controls) and APD90 (208 ± 4 vs 228 ± 3 ms in controls) were shorter (P <0.01). The plateau potential in both right and left ventricular tissue was significantly higher in inbred turkeys.Since a spectrum of cardiac dilatation and hypertrophy is present in myopathic turkeys, we examined the effect of hypertrophy on action potential characteristics. In "round heart disease" turkeys, left ventricular hypertrophy was characterised by reduced dV/dtmax (98 ± vs 274 ± 26 V s-1, P <0.01) and right ventricular hypertrophy by further shortening of both APD50 (174 ± 7 vs 202 ± 6 ms, P <0.01) and APD90 (193 ± vs 224 ± 5 ms, P <0.01), but no change in dV/dtmax (105 ± 13 vs 120 ± 9 V s-1, P = NS). These results indicate that certain electrophysiological differences (eg reduced action potential duration), may, in part, contribute to dysrhythmia susceptibility in this presumed viral cardiomyopathy model.
UR - http://www.scopus.com/inward/record.url?scp=85047679399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047679399&partnerID=8YFLogxK
U2 - 10.1093/cvr/15.11.643
DO - 10.1093/cvr/15.11.643
M3 - Review article
C2 - 6459849
AN - SCOPUS:85047679399
SN - 0008-6363
VL - 15
SP - 643
EP - 651
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 11
ER -